Sensitive detection and identification method of erythrocyte-like cells upon doxorubicin induced differentiation with vibrational techniques

18 April 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Altered differentiation of blood cell precursors and their clonal expansion occurs in various types of leukaemia. One treatment strategy is to induce differentiation into the mature form, which is capable of undergoing apoptosis. It has been found that low doses of doxorubicin (DOX) induce phenotypic and morphological changes in malignant erythroid precursors to erythrocyte-like cells. These are usually studied by time-consuming examination of haemoglobinisation by benzidine staining or glycophorin A expression by Western blot or flow cytometry. As an alternative, we propose an in-depth investigation of DOX-induced erythroid differentiation using Raman spectroscopy and stimulated Raman scattering microscopy and fast and sensitive classification using the probe for mitochondrial imaging (MitoBADY). Machine learning methods, including Orthogonal Partial Least Squares, Principal Component Analysis, and Multivariate Curve Resolution-Alternating Least Squares, etc., were implemented to extract spectroscopic markers of differentiation from both single spectra and the hyperspectral images.

Keywords

Raman probe
erythroid induced differentiation
mitochondria

Supplementary materials

Title
Description
Actions
Title
SI Sensitive detection and identification method of erythrocyte-like cells upon doxorubicin induced differentiation with vibrational techniques
Description
Supporting Information
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.